INTELLIGENT BIO SOLUTIONS INC. (INBS)
$2.28+$0.09 (+3.96%) Today
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.
No Form 4 activity for INBS in the last 90 days.
6 Form 4 filings on record, the earliest from Mar 20, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Steven Constantine Boyages - Director | Grant or award | Common Stock | 5,000 | $0.00 | - | |
| Nicola Marion Fraser - Director | Grant or award | Common Stock | 5,000 | $0.00 | - | |
| Spiro Kevin Sakiris - Officer | Grant or award | Common Stock | 9,150 | $0.00 | - | |
| Spiro Kevin Sakiris - Officer | Grant or award | Common Stock | 21,350 | $0.00 | - | |
| Jonathan Scott Hurd - Director | Grant or award | Common Stock | 5,000 | $0.00 | - | |
| Jason Isenberg - Director | Grant or award | Common Stock | 5,000 | $0.00 | - | |
| Harry Simeonidis - Officer | Grant or award | Common Stock | 9,150 | $0.00 | - | |
| Harry Simeonidis - Officer | Grant or award | Common Stock | 21,350 | $0.00 | - |
INTELLIGENT BIO SOLUTIONS INC. (INBS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-03-20. The full record for INBS runs to 6 Form 4 filings, the earliest from 2026-03-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of INBS were filed in the last 90 days.
No insider sales of INBS were filed in the last 90 days.
This page tracks INBS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add INBS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
